Require Prescription
Description:
Nucala 100 mg Powder For Solution For Injection is a medication used to treat severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis (EGPA). It helps reduce inflammation caused by high levels of eosinophils in the blood and tissues.
Ingredients:
Each vial contains 100 mg of Mepolizumab as the active ingredient, along with other inactive ingredients necessary to formulate the injection.
Usage Instructions:
Nucala is administered as a subcutaneous injection by a healthcare professional. The usual dose is 100 mg once every 4 weeks. The injection site should be rotated, and proper aseptic technique should be followed.
Benefits:
- Reduces exacerbations and improves asthma control in patients with severe eosinophilic asthma.
- Helps manage symptoms and reduce the need for oral corticosteroids in EGPA patients.
Precautions:
- May increase the risk of certain infections.
- Monitor for hypersensitivity reactions during and after administration.
- Not recommended for use during pregnancy unless clearly needed.
Storage Instructions:
Store Nucala powder vials in the refrigerator between 2°C to 8°C (36°F to 46°F). Protect from light. Once reconstituted, use immediately or store at room temperature (up to 25°C or 77°F) for up to 8 hours.
Manufacturer:
GlaxoSmithKline
